Cite
HARVARD Citation
Herzog, T. et al. (n.d.). TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. International journal of gynecological cancer. p. A235. [Online].